Michael R Hayden bought $570K of ABCL stock

Michael R Hayden, Dir of AbCellera Biologics Inc. (ABCL), bought 53,613 shares of ABCL stock worth $570K, per an SEC Form 4 filed Aug 24, 2026.

It was an open-market purchase.

The trade was reported on Aug 24, 2026.

ABCL has moved +8.3% since the trade date, from $10.61 to $11.49 (Nov 13, 2026 close).